NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB)

CUSIP: 63937X103

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / COM
Total 13F shares
13,836,188
Share change
-50,626
Total reported value
$5,757,000
Price per share
$0.41
Number of holders
50
Value change
-$19,489
Number of buys
16
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 63937X103?
CUSIP 63937X103 identifies NAVB - NAVIDEA BIOPHARMACEUTICALS I - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB) as of Q3 2017

As of 30 Sep 2017, NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB) was held by 50 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,836,188 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., Harel Insurance Investments & Financial Services Ltd., GEODE CAPITAL MANAGEMENT, LLC, Sowell Financial Services LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, JACOBS LEVY EQUITY MANAGEMENT, INC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, GOLDMAN SACHS GROUP INC, and NORTHERN TRUST CORP. This page lists 50 institutional shareholders reporting positions in this security for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.